Europe Synthetic Peptide Vaccine Market Report 2017

Europe Synthetic Peptide Vaccine Market Report 2017

1 Synthetic Peptide Vaccine Overview

1.1 Product Overview and Scope of Synthetic Peptide Vaccine

1.2 Classification of Synthetic Peptide Vaccine

1.2.1 Type I

1.2.2 Type II

1.3 Application of Synthetic Peptide Vaccine

1.3.1 Application 1

1.3.2 Application 2

1.4 Synthetic Peptide Vaccine Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Synthetic Peptide Vaccine (2012-2022)

1.5.1 Europe Synthetic Peptide Vaccine Sales and Growth Rate (2012-2022)

1.5.2 Europe Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

2 Europe Synthetic Peptide Vaccine by Manufacturers, Type and Application

2.1 Europe Synthetic Peptide Vaccine Market Competition by Manufacturers

2.1.1 Europe Synthetic Peptide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Synthetic Peptide Vaccine Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Synthetic Peptide Vaccine (Volume and Value) by Type

2.2.1 Europe Synthetic Peptide Vaccine Sales and Market Share by Type (2012-2017)

2.2.2 Europe Synthetic Peptide Vaccine Revenue and Market Share by Type (2012-2017)

2.3 Europe Synthetic Peptide Vaccine (Volume and Value) by Countries

2.3.1 Europe Synthetic Peptide Vaccine Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Synthetic Peptide Vaccine Revenue and Market Share by Countries (2012-2017)

2.4 Europe Synthetic Peptide Vaccine (Volume) by Application

3 Germany Synthetic Peptide Vaccine (Volume, Value and Sales Price)

3.1 Germany Synthetic Peptide Vaccine Sales and Value (2012-2017)

3.1.1 Germany Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

3.1.2 Germany Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

3.1.3 Germany Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

3.2 Germany Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

3.3 Germany Synthetic Peptide Vaccine Sales and Market Share by Type

3.4 Germany Synthetic Peptide Vaccine Sales and Market Share by Application

4 France Synthetic Peptide Vaccine (Volume, Value and Sales Price)

4.1 France Synthetic Peptide Vaccine Sales and Value (2012-2017)

4.1.1 France Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

4.1.2 France Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

4.1.4 France Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

4.2 France Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

4.3 France Synthetic Peptide Vaccine Sales and Market Share by Type

4.4 France Synthetic Peptide Vaccine Sales and Market Share by Application

5 UK Synthetic Peptide Vaccine (Volume, Value and Sales Price)

5.1 UK Synthetic Peptide Vaccine Sales and Value (2012-2017)

5.1.1 UK Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

5.1.2 UK Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

5.1.5 UK Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

5.2 UK Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

5.3 UK Synthetic Peptide Vaccine Sales and Market Share by Type

5.4 UK Synthetic Peptide Vaccine Sales and Market Share by Application

6 Russia Synthetic Peptide Vaccine (Volume, Value and Sales Price)

6.1 Russia Synthetic Peptide Vaccine Sales and Value (2012-2017)

6.1.1 Russia Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

6.1.2 Russia Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

6.1.6 Russia Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

6.2 Russia Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

6.3 Russia Synthetic Peptide Vaccine Sales and Market Share by Type

6.4 Russia Synthetic Peptide Vaccine Sales and Market Share by Application

7 Italy Synthetic Peptide Vaccine (Volume, Value and Sales Price)

7.1 Italy Synthetic Peptide Vaccine Sales and Value (2012-2017)

7.1.1 Italy Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

7.1.2 Italy Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

7.1.7 Italy Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

7.2 Italy Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

7.3 Italy Synthetic Peptide Vaccine Sales and Market Share by Type

7.4 Italy Synthetic Peptide Vaccine Sales and Market Share by Application

8 Spain Synthetic Peptide Vaccine (Volume, Value and Sales Price)

8.1 Spain Synthetic Peptide Vaccine Sales and Value (2012-2017)

8.1.1 Spain Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

8.1.2 Spain Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

8.1.8 Spain Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

8.2 Spain Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

8.3 Spain Synthetic Peptide Vaccine Sales and Market Share by Type

8.4 Spain Synthetic Peptide Vaccine Sales and Market Share by Application

9 Benelux Synthetic Peptide Vaccine (Volume, Value and Sales Price)

9.1 Benelux Synthetic Peptide Vaccine Sales and Value (2012-2017)

9.1.1 Benelux Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

9.1.2 Benelux Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

9.2 Benelux Synthetic Peptide Vaccine Sales and Market Share by Manufacturers

9.3 Benelux Synthetic Peptide Vaccine Sales and Market Share by Type

9.4 Benelux Synthetic Peptide Vaccine Sales and Market Share by Application

10 Europe Synthetic Peptide Vaccine Manufacturers Analysis

10.1 Artificial Cell Technologies

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Benovus Bio

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Bionor Pharma

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Bionor Pharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Circassia

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Circassia Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Celgene Corporation

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Galena Biopharma

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 Galena Biopharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Immatics biotechnologies

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Immune Design

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 Immune Design Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 ImmunoCellular Therapeutics

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.9.2.1 Product A

10.9.2.2 Product B

10.9.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Invectys

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Synthetic Peptide Vaccine Product Type, Application and Specification

10.10.2.1 Product A

10.10.2.2 Product B

10.10.3 Invectys Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 ISA Pharmaceuticals

10.12 Lytix Biopharma

10.13 Medinet

10.14 Memcine Pharmaceuticals

10.15 Merck Serono

10.16 OncoTherapy Science

11 Synthetic Peptide Vaccine Manufacturing Cost Analysis

11.1 Synthetic Peptide Vaccine Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Synthetic Peptide Vaccine

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Synthetic Peptide Vaccine Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Synthetic Peptide Vaccine Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Synthetic Peptide Vaccine Market Forecast (2017-2022)

14.1 Germany Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.2 France Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.3 UK Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.4 Russia Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.5 Italy Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.6 Spain Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.7 Benelux Synthetic Peptide Vaccine Sales Forecast (2017-2022)

14.8 Europe Synthetic Peptide Vaccine Sales Forecast by Type (2017-2022)

14.9 Europe Synthetic Peptide Vaccine Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Synthetic Peptide Vaccine

Table Classification of Synthetic Peptide Vaccine

Figure Europe Sales Market Share of Synthetic Peptide Vaccine by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Synthetic Peptide Vaccine

Figure Europe Sales Market Share of Synthetic Peptide Vaccine by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure France Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure UK Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Russia Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Italy Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Spain Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Benelux Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Europe Synthetic Peptide Vaccine Sales and Growth Rate (2012-2022)

Figure Europe Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

Table Europe Synthetic Peptide Vaccine Sales of Key Manufacturers (2015 and 2016)

Table Europe Synthetic Peptide Vaccine Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Synthetic Peptide Vaccine Sales Share by Manufacturers

Figure 2016 Synthetic Peptide Vaccine Sales Share by Manufacturers

Table Europe Synthetic Peptide Vaccine Revenue by Manufacturers (2015 and 2016)

Table Europe Synthetic Peptide Vaccine Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Synthetic Peptide Vaccine Revenue Share by Manufacturers

Table 2016 Europe Synthetic Peptide Vaccine Revenue Share by Manufacturers

Table Europe Synthetic Peptide Vaccine Sales and Market Share by Type (2012-2017)

Table Europe Synthetic Peptide Vaccine Sales Share by Type (2012-2017)

Figure Sales Market Share of Synthetic Peptide Vaccine by Type (2012-2017)

Figure Europe Synthetic Peptide Vaccine Sales Growth Rate by Type (2012-2017)

Table Europe Synthetic Peptide Vaccine Revenue and Market Share by Type (2012-2017)

Table Europe Synthetic Peptide Vaccine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Synthetic Peptide Vaccine by Type (2012-2017)

Figure Europe Synthetic Peptide Vaccine Revenue Growth Rate by Type (2012-2017)

Table Europe Synthetic Peptide Vaccine Sales and Market Share by Countries (2012-2017)

Table Europe Synthetic Peptide Vaccine Sales Share by Countries (2012-2017)

Figure Sales Market Share of Synthetic Peptide Vaccine by Countries (2012-2017)

Table Europe Synthetic Peptide Vaccine Revenue and Market Share by Countries (2012-2017)

Table Europe Synthetic Peptide Vaccine Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Synthetic Peptide Vaccine by Countries (2012-2017)

Table Europe Synthetic Peptide Vaccine Sales and Market Share by Application (2012-2017)

Table Europe Synthetic Peptide Vaccine Sales Share by Application (2012-2017)

Figure Sales Market Share of Synthetic Peptide Vaccine by Application (2012-2017)

Figure Germany Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Germany Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Germany Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table Germany Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Germany Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Germany Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table Germany Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table Germany Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table Germany Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Figure France Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure France Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure France Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table France Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table France Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table France Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table France Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table France Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table France Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Figure UK Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure UK Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure UK Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table UK Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table UK Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table UK Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table UK Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table UK Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table UK Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Russia Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Russia Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Russia Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table Russia Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Russia Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Russia Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table Russia Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table Russia Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table Russia Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Italy Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Italy Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Italy Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table Italy Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Italy Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Italy Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table Italy Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table Italy Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table Italy Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Spain Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Spain Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Spain Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table Spain Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Spain Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Spain Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table Spain Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table Spain Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table Spain Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Benelux Synthetic Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Benelux Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Benelux Synthetic Peptide Vaccine Sales Price Trend (2012-2017)

Table Benelux Synthetic Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Benelux Synthetic Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Benelux Synthetic Peptide Vaccine Sales by Type (2015 and 2016)

Table Benelux Synthetic Peptide Vaccine Market Share by Type (2015 and 2016)

Table Benelux Synthetic Peptide Vaccine Sales by Application (2015 and 2016)

Table Benelux Synthetic Peptide Vaccine Market Share by Application (2015 and 2016)

Table Synthetic Peptide Vaccine Basic Information List

Table Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Artificial Cell Technologies Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Benovus Bio Basic Information List

Table Benovus Bio Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Benovus Bio Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Bionor Pharma Basic Information List

Table Bionor Pharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bionor Pharma Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Circassia Basic Information List

Table Circassia Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Circassia Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Celgene Corporation Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Galena Biopharma Basic Information List

Table Galena Biopharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Galena Biopharma Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Immatics biotechnologies Basic Information List

Table Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Immatics biotechnologies Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Immune Design Basic Information List

Table Immune Design Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Immune Design Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table ImmunoCellular Therapeutics Basic Information List

Table ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table Invectys Basic Information List

Table Invectys Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Invectys Synthetic Peptide Vaccine Sales Market Share (2012-2017)

Table ISA Pharmaceuticals Basic Information List

Table Lytix Biopharma Basic Information List

Table Medinet Basic Information List

Table Memcine Pharmaceuticals Basic Information List

Table Merck Serono Basic Information List

Table OncoTherapy Science Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Synthetic Peptide Vaccine

Figure Manufacturing Process Analysis of Synthetic Peptide Vaccine

Figure Synthetic Peptide Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Synthetic Peptide Vaccine Major Manufacturers in 2015

Table Major Buyers of Synthetic Peptide Vaccine

Table Distributors/Traders List

Figure Germany Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Germany Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure France Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure France Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure UK Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure UK Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Russia Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Italy Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Spain Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Synthetic Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Synthetic Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Table Europe Synthetic Peptide Vaccine Sales Forecast by Type (2017-2022)

Table Europe Synthetic Peptide Vaccine Sales Forecast by Application (2017-2022)